All Outputs (3)

The incidence and determinants of metabolic syndrome amongst a group of migrants to Qatar: a prospective longitudinal observational cohort study 24-months post-migration. (2021)
Journal Article
AL-ADAWI, R.M., PRABHU, K.S., STEWART, D., RYAN, C., ABDELAZIZ, H., ELEDRISI, M., IBRAHIM, M.I.M., UDDIN, S. and TONNA, A.P. 2022. The incidence and determinants of metabolic syndrome amongst a group of migrants to Qatar: a prospective longitudinal observational cohort study 24-months post-migration. Journal of clinical medicine [online], 11(1), article 34. Available from: https://doi.org/10.3390/jcm11010034

While there is some evidence that migration to Western countries increases metabolic syndrome (MetS) risk, there is a lack of data pertaining to migration to the Middle East. This study aimed to investigate the relationship between migration and MetS... Read More about The incidence and determinants of metabolic syndrome amongst a group of migrants to Qatar: a prospective longitudinal observational cohort study 24-months post-migration..

The incidence of metabolic syndrome amongst Qatar migrants 24 months post-migration: a prospective longitudinal observational cohort study. (2021)
Presentation / Conference
AL-ADAWI, R., PRABHU, K.S., RYAN, C., ABDELAZIZ, H., EL EDRISI, M. and IBRAHIM, M.I.M. 2021. The incidence of metabolic syndrome amongst Qatar migrants 24 month post-migration: a prospective longiudinal observational cohort study. Presented at 49th ESCP (European Society of Clinical Pharmacy) virtual symposium on clinical pharmacy (ESCP 2021): clinical pharmacy, working collaboratively in mental health care, 19-21 October 2021, [virtual conference].

Background and Objective: Evidence indicates that migration to Western countries is associated with increased metabolic syndrome (MetS) risk. There is, however, a scarcity of data about MetS incidence in migrants to Middle Eastern countries. This stu... Read More about The incidence of metabolic syndrome amongst Qatar migrants 24 months post-migration: a prospective longitudinal observational cohort study..

Incidence of co-trimoxazole-induced hyperkalemia in a tertiary care hospital. (2021)
Journal Article
AL ADAWI, R.M., ALBU-MAHMOOD, Z., ABDELGELIL, M., ABDELAZIZ, H., STEWART, D. and AWAISU, A. 2021. Incidence of co-trimoxazole-induced hyperkalemia in a tertiary care hospital. Risk management and healthcare policy [online], 14, pages 519-525. Available from: https://doi.org/10.2147/RMHP.S283471

Co-trimoxazole is a broad-spectrum antibiotic associated with hyperkalemia. To determine the incidence of hyperkalemia and its risk factors in patients receiving co-trimoxazole. A retrospective observational study involving all patients who received... Read More about Incidence of co-trimoxazole-induced hyperkalemia in a tertiary care hospital..